ATE85521T1 - Verwendung von acetyl-l-carnitin zur herstellung eines arzneimittels zur therapeutischen behandlung von schockzustaenden. - Google Patents

Verwendung von acetyl-l-carnitin zur herstellung eines arzneimittels zur therapeutischen behandlung von schockzustaenden.

Info

Publication number
ATE85521T1
ATE85521T1 AT86830296T AT86830296T ATE85521T1 AT E85521 T1 ATE85521 T1 AT E85521T1 AT 86830296 T AT86830296 T AT 86830296T AT 86830296 T AT86830296 T AT 86830296T AT E85521 T1 ATE85521 T1 AT E85521T1
Authority
AT
Austria
Prior art keywords
acetyl
carnitine
medication
manufacture
therapeutic treatment
Prior art date
Application number
AT86830296T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE85521T1 publication Critical patent/ATE85521T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT86830296T 1985-10-14 1986-10-13 Verwendung von acetyl-l-carnitin zur herstellung eines arzneimittels zur therapeutischen behandlung von schockzustaenden. ATE85521T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48663/85A IT1184655B (it) 1985-10-14 1985-10-14 Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock
EP86830296A EP0225856B1 (de) 1985-10-14 1986-10-13 Verwendung von Acetyl-L-carnitin zur Herstellung eines Arzneimittels zur therapeutischen Behandlung von Schockzuständen

Publications (1)

Publication Number Publication Date
ATE85521T1 true ATE85521T1 (de) 1993-02-15

Family

ID=11267907

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86830296T ATE85521T1 (de) 1985-10-14 1986-10-13 Verwendung von acetyl-l-carnitin zur herstellung eines arzneimittels zur therapeutischen behandlung von schockzustaenden.

Country Status (8)

Country Link
US (1) US4771075A (de)
EP (1) EP0225856B1 (de)
JP (1) JPH0780765B2 (de)
AT (1) ATE85521T1 (de)
DE (1) DE3687742T2 (de)
ES (1) ES2043608T3 (de)
GR (1) GR3007026T3 (de)
IT (1) IT1184655B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235153B (it) * 1988-11-15 1992-06-22 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
IT1244636B (it) * 1991-01-04 1994-08-08 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
IT1254331B (it) * 1992-04-23 1995-09-14 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1261828B (it) * 1993-07-14 1996-06-03 Sigma Tau Ind Farmaceuti Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1142934B (it) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Also Published As

Publication number Publication date
EP0225856B1 (de) 1993-02-10
IT1184655B (it) 1987-10-28
EP0225856A3 (en) 1989-06-07
JPS6296423A (ja) 1987-05-02
US4771075A (en) 1988-09-13
DE3687742T2 (de) 1993-05-27
ES2043608T3 (es) 1994-01-01
JPH0780765B2 (ja) 1995-08-30
GR3007026T3 (de) 1993-07-30
IT8548663A0 (it) 1985-10-14
EP0225856A2 (de) 1987-06-16
DE3687742D1 (de) 1993-03-25

Similar Documents

Publication Publication Date Title
Skyhar et al. Hyperbaric oxygen reduces edema and necrosis of skeletal muscle in compartment syndromes associated with hemorrhagic hypotension.
DE3687501D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
US3860706A (en) Method for curing stock symptoms
ATE85521T1 (de) Verwendung von acetyl-l-carnitin zur herstellung eines arzneimittels zur therapeutischen behandlung von schockzustaenden.
DE3686520D1 (de) Verwendung von einigen alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur therapeutischen behandlung von ideopathischem oder induziertem parkinsonismus.
Liebowitz et al. Anaphylactic reaction to chymotrypsin
DE19975044I2 (de) Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten
IT1254331B (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
KR100198176B1 (ko) 엔도톡신 혈증 및 그것에 의해 유발되는 다장기 부전증의 치료약
ATE31022T1 (de) Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten.
Muir et al. Antiarrhythmic effects of diazepam during coronary artery occlusion in dogs
Strong et al. Paroxysmal ventricular tachycardia: With report of an unusual case
LEAR INTRAVENOUS ANESTHESIA..... a survey of newer agents
KRENZELOK et al. Dextran 40 anaphylaxis
CA2213775C (en) Cancer metastasis inhibitor containing a streptococcus agalactiae ia type or ib type surface polysaccharide as a main ingredient
HEWLETT The Action of Tyramin on the Circulation of Man
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
DE345883T1 (de) Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin.
ATE185484T1 (de) Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge
Messinger et al. Cardiovascular effects of large doses of metrazol as employed in the treatment of schizophrenia
SU1291153A1 (ru) Способ лечени неврологических расстройств,обусловленных т желой черепно-мозговой травмой
Hiatt et al. Renal hyperemia in dogs induced by oral administration of cinchona alkaloids
RU96104214A (ru) Способ лечения транссудативных форм центральных хориоретинальных дистрофий
Kott et al. Intra-arterial barbiturate injection in a drug addict

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee